FI952141A - Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisia - Google Patents

Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisia Download PDF

Info

Publication number
FI952141A
FI952141A FI952141A FI952141A FI952141A FI 952141 A FI952141 A FI 952141A FI 952141 A FI952141 A FI 952141A FI 952141 A FI952141 A FI 952141A FI 952141 A FI952141 A FI 952141A
Authority
FI
Finland
Prior art keywords
pct
compound
hydraninopyridine
derivatives
date
Prior art date
Application number
FI952141A
Other languages
English (en)
Swedish (sv)
Other versions
FI113044B (fi
FI952141A0 (fi
Inventor
Michael Jeffrey Abrams
Gary James Bridger
David Aaron Schwartz
Sreenivasan Padmanabhan
Michael Evert Ultee
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of FI952141A publication Critical patent/FI952141A/fi
Publication of FI952141A0 publication Critical patent/FI952141A0/fi
Application granted granted Critical
Publication of FI113044B publication Critical patent/FI113044B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Peptides Or Proteins (AREA)
FI952141A 1992-11-05 1995-05-04 2-hydratsinopyridiinijohdannaisia FI113044B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9223168 1992-11-05
GB929223168A GB9223168D0 (en) 1992-11-05 1992-11-05 Improvements in molecule labelling
GB9302259 1993-02-05
PCT/GB1993/002259 WO1994010149A1 (en) 1992-11-05 1993-11-03 Molecule labelling using 2-hydraninopyridine derivatives

Publications (3)

Publication Number Publication Date
FI952141A true FI952141A (fi) 1995-05-04
FI952141A0 FI952141A0 (fi) 1995-05-04
FI113044B FI113044B (fi) 2004-02-27

Family

ID=10724568

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952141A FI113044B (fi) 1992-11-05 1995-05-04 2-hydratsinopyridiinijohdannaisia

Country Status (19)

Country Link
US (1) US5679778A (fi)
EP (1) EP0667859B1 (fi)
JP (1) JP3542597B2 (fi)
KR (1) KR100295545B1 (fi)
AT (1) ATE195730T1 (fi)
AU (1) AU676863B2 (fi)
CA (1) CA2148595C (fi)
DE (1) DE69329293T2 (fi)
DK (1) DK0667859T3 (fi)
ES (1) ES2150950T3 (fi)
FI (1) FI113044B (fi)
GB (1) GB9223168D0 (fi)
GR (1) GR3034883T3 (fi)
HK (1) HK1013420A1 (fi)
HU (1) HU226459B1 (fi)
NO (1) NO305364B1 (fi)
NZ (1) NZ257376A (fi)
PT (1) PT667859E (fi)
WO (1) WO1994010149A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
ES2398118T3 (es) 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
US6403054B1 (en) * 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6844333B1 (en) * 1999-03-26 2005-01-18 The Trustees Of The University Of Pennsylvania Method of treating atherosclerosis
AU2001247697B2 (en) * 2000-03-22 2006-06-22 Solulink, Incorporated Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US6686461B1 (en) 2000-03-22 2004-02-03 Solulink Bioscience, Inc. Triphosphate oligonucleotide modification reagents and uses thereof
US7102024B1 (en) 2000-08-01 2006-09-05 Schwartz David A Functional biopolymer modification reagents and uses thereof
US6843980B2 (en) 2001-04-03 2005-01-18 Theseus Imaging, Corp. Methods for using annexin for detecting cell death in vivo and treating associated conditions
EP1381839A4 (en) 2001-04-03 2005-10-12 Univ Leland Stanford Junior METHOD FOR THE IMAGE OF CELL DEOD IN VIVO
GB0130845D0 (en) * 2001-12-22 2002-02-06 James Peter Analysis
US7158353B2 (en) * 2003-11-06 2007-01-02 Seagate Technology Llc Magnetoresistive sensor having specular sidewall layers
JP5107716B2 (ja) * 2004-11-05 2012-12-26 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 分子治療用生分解性リンカー
CN103403011A (zh) * 2011-01-31 2013-11-20 Eth苏黎世公司 三官能交联试剂
JP6415979B2 (ja) 2011-06-03 2018-10-31 スリーエム イノベイティブ プロパティズ カンパニー ヒドラジノ1h−イミダゾキノリン−4−アミン及びこれから調製された複合体
MX347240B (es) 2011-06-03 2017-04-20 3M Innovative Properties Co Ligadores heterobifuncionales con segmentos polietilenglicol y conjugados modificadores de la respuesta inmunitaria elaborados a partir de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use

Also Published As

Publication number Publication date
KR100295545B1 (ko) 2001-09-17
ES2150950T3 (es) 2000-12-16
JPH08502744A (ja) 1996-03-26
KR950704256A (ko) 1995-11-17
ATE195730T1 (de) 2000-09-15
NZ257376A (en) 1996-02-27
CA2148595A1 (en) 1994-05-11
DK0667859T3 (da) 2000-10-16
HUT72332A (en) 1996-04-29
AU676863B2 (en) 1997-03-27
JP3542597B2 (ja) 2004-07-14
DE69329293T2 (de) 2000-12-28
FI113044B (fi) 2004-02-27
HU226459B1 (en) 2008-12-29
CA2148595C (en) 2002-05-21
FI952141A0 (fi) 1995-05-04
AU5375594A (en) 1994-05-24
PT667859E (pt) 2001-02-28
WO1994010149A1 (en) 1994-05-11
GR3034883T3 (en) 2001-02-28
GB9223168D0 (en) 1992-12-16
NO951751D0 (no) 1995-05-04
HK1013420A1 (en) 1999-08-27
DE69329293D1 (de) 2000-09-28
EP0667859A1 (en) 1995-08-23
NO305364B1 (no) 1999-05-18
EP0667859B1 (en) 2000-08-23
US5679778A (en) 1997-10-21
NO951751L (no) 1995-06-12

Similar Documents

Publication Publication Date Title
FI952141A (fi) Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisia
NO20003133D0 (no) Anilidderivater, fremstilling og anvendelse derav
FI914163A0 (fi) Heterocykliska derivat.
NO20031490L (no) Alifatisk nitrogenholdig 5-kantet ring-forbindelse
AU3141693A (en) Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
ATE416186T1 (de) Phenylethylenamin-derivate
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
FI903917A0 (fi) Foerfarande foer framstaellning av med metallradionuklider maerkta proteiner.
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
SE8505716D0 (sv) Novel compounds and conjugates thereof
ES2104682T3 (es) Fluor-compuestos.
CA2211385A1 (en) N-1-carboxyalkyl derivatives of lsd
ES2098338T3 (es) Heteroarilmetilbencenos.
DE50004382D1 (de) Verfahren zur Herstellung von Guanidinderivaten
BR9610804A (pt) Processo para preparar um composto composto e sal dissódico
ES2099963T3 (es) Sintesis de indoles mediante deshidrogenacion de indolinas.
KR850005830A (ko) 2-알콕시아미노설포닐벤젠-설포닐우레아의 제조방법
FR2645535B1 (fr) Preparation d'ethenes substitues
KR960704889A (ko) 인돌리진 유도체의 제조방법 (Process for the preparation of indolizine derivatives)
KR920002550A (ko) 6-알킬피리다진 유도체, 그의 제법 및 그를 함유하는 약학 조성물
KR920004377A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약제학적 조성물
KR910007952A (ko) 신규 안트라사이클린 글리코사이드 유도체
TH16053A (fi)
TW352391B (en) Novel cyanine dyes, the intermediates and preparation thereof
KR940014350A (ko) 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ANORMED INC.

MA Patent expired